Tellgen Past Earnings Performance
Past criteria checks 0/6
Tellgen's earnings have been declining at an average annual rate of -6%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 10.3% per year. Tellgen's return on equity is 4.5%, and it has net margins of 14.4%.
Key information
-6.0%
Earnings growth rate
-6.1%
EPS growth rate
Medical Equipment Industry Growth | 16.0% |
Revenue growth rate | 10.3% |
Return on equity | 4.5% |
Net Margin | 14.4% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Tellgen makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 514 | 74 | 215 | 77 |
31 Dec 23 | 543 | 89 | 219 | 78 |
30 Sep 23 | 607 | 99 | 234 | 84 |
30 Jun 23 | 671 | 117 | 249 | 86 |
31 Mar 23 | 693 | 131 | 241 | 81 |
01 Jan 23 | 716 | 125 | 242 | 79 |
30 Sep 22 | 719 | 144 | 246 | 77 |
30 Jun 22 | 672 | 129 | 238 | 71 |
31 Mar 22 | 681 | 143 | 239 | 74 |
31 Dec 21 | 655 | 161 | 232 | 73 |
30 Sep 21 | 673 | 192 | 204 | 65 |
30 Jun 21 | 675 | 204 | 189 | 68 |
31 Mar 21 | 579 | 163 | 165 | 65 |
31 Dec 20 | 490 | 121 | 152 | 61 |
30 Sep 20 | 421 | 93 | 148 | 60 |
30 Jun 20 | 384 | 94 | 138 | 54 |
31 Mar 20 | 403 | 122 | 138 | 53 |
31 Dec 19 | 441 | 157 | 133 | 52 |
30 Sep 19 | 416 | 149 | 128 | 50 |
30 Jun 19 | 399 | 145 | 122 | 47 |
31 Mar 19 | 379 | 144 | 114 | 42 |
31 Dec 18 | 365 | 142 | 108 | 40 |
30 Sep 18 | 349 | 140 | 100 | 38 |
30 Jun 18 | 324 | 131 | 79 | 47 |
31 Mar 18 | 313 | 127 | 79 | 38 |
31 Dec 17 | 303 | 127 | 78 | 30 |
30 Sep 17 | 271 | 113 | 77 | 20 |
30 Jun 17 | 256 | 106 | 91 | 0 |
31 Mar 17 | 240 | 99 | 84 | 0 |
31 Dec 16 | 231 | 98 | 79 | 0 |
30 Jun 16 | 195 | 80 | 70 | 0 |
31 Mar 16 | 171 | 65 | 66 | 0 |
31 Dec 15 | 169 | 66 | 64 | 0 |
31 Dec 14 | 118 | 36 | 54 | 0 |
31 Dec 13 | 77 | 23 | 37 | 0 |
Quality Earnings: 300642 has a large one-off gain of CN¥17.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 300642's current net profit margins (14.4%) are lower than last year (18.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300642's earnings have declined by 6% per year over the past 5 years.
Accelerating Growth: 300642's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300642 had negative earnings growth (-43.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (-1.3%).
Return on Equity
High ROE: 300642's Return on Equity (4.5%) is considered low.